These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37569634)

  • 1. Application of Quantitative Structure-Activity Relationships in the Prediction of New Compounds with Anti-Leukemic Activity.
    Sandoval C; Torrens F; Godoy K; Reyes C; Farías J
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of novel PRMT1 inhibitors and investigation of their binding preferences using molecular modelling.
    Yang H; Ouyang Y; Ma H; Cong H; Zhuang C; Lok WT; Wang Z; Zhu X; Sun Y; Hong W; Wang H
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4635-4642. PubMed ID: 28927791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of cyanine compounds as selective inhibitors of protein arginine methyltransferases: synthesis and biological evaluation.
    Hu H; Owens EA; Su H; Yan L; Levitz A; Zhao X; Henary M; Zheng YG
    J Med Chem; 2015 Feb; 58(3):1228-43. PubMed ID: 25559100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Development of Tetrazole Derivatives as Protein Arginine Methyltransferase I (PRMT I) Inhibitors.
    Sun Y; Wang Z; Yang H; Zhu X; Wu H; Ma L; Xu F; Hong W; Wang H
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31390828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD
    He X; Zhu Y; Lin YC; Li M; Du J; Dong H; Sun J; Zhu L; Wang H; Ding Z; Zhang L; Zhang L; Zhao D; Wang Z; Wu H; Zhang H; Jiang W; Xu Y; Jin J; Shen Y; Perry J; Zhao X; Zhang B; Liu S; Xue SL; Shen B; Chen CW; Chen J; Khaled S; Kuo YH; Marcucci G; Luo Y; Li L
    Blood; 2019 Aug; 134(6):548-560. PubMed ID: 31217189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and biochemical evaluation of bisubstrate inhibitors of protein arginine N-methyltransferases PRMT1 and CARM1 (PRMT4).
    Gunnell EA; Al-Noori A; Muhsen U; Davies CC; Dowden J; Dreveny I
    Biochem J; 2020 Feb; 477(4):787-800. PubMed ID: 32011657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diamidine compounds for selective inhibition of protein arginine methyltransferase 1.
    Yan L; Yan C; Qian K; Su H; Kofsky-Wofford SA; Lee WC; Zhao X; Ho MC; Ivanov I; Zheng YG
    J Med Chem; 2014 Mar; 57(6):2611-22. PubMed ID: 24564570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity-based protein profiling of protein arginine methyltransferase 1.
    Obianyo O; Causey CP; Jones JE; Thompson PR
    ACS Chem Biol; 2011 Oct; 6(10):1127-35. PubMed ID: 21838253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule inhibitors that discriminate between protein arginine N-methyltransferases PRMT1 and CARM1.
    Dowden J; Pike RA; Parry RV; Hong W; Muhsen UA; Ward SG
    Org Biomol Chem; 2011 Oct; 9(22):7814-21. PubMed ID: 21952734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel inhibitors for PRMT1 discovered by high-throughput screening using activity-based fluorescence polarization.
    Dillon MB; Bachovchin DA; Brown SJ; Finn MG; Rosen H; Cravatt BF; Mowen KA
    ACS Chem Biol; 2012 Jul; 7(7):1198-204. PubMed ID: 22506763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual screening and biological evaluation of novel small molecular inhibitors against protein arginine methyltransferase 1 (PRMT1).
    Xie Y; Zhou R; Lian F; Liu Y; Chen L; Shi Z; Zhang N; Zheng M; Shen B; Jiang H; Liang Z; Luo C
    Org Biomol Chem; 2014 Dec; 12(47):9665-73. PubMed ID: 25348815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity.
    Zhao X; Jankovic V; Gural A; Huang G; Pardanani A; Menendez S; Zhang J; Dunne R; Xiao A; Erdjument-Bromage H; Allis CD; Tempst P; Nimer SD
    Genes Dev; 2008 Mar; 22(5):640-53. PubMed ID: 18316480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer.
    Avasarala S; Van Scoyk M; Karuppusamy Rathinam MK; Zerayesus S; Zhao X; Zhang W; Pergande MR; Borgia JA; DeGregori J; Port JD; Winn RA; Bikkavilli RK
    J Biol Chem; 2015 May; 290(21):13479-89. PubMed ID: 25847239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein arginine methyltransferase 1 and 8 interact with FUS to modify its sub-cellular distribution and toxicity in vitro and in vivo.
    Scaramuzzino C; Monaghan J; Milioto C; Lanson NA; Maltare A; Aggarwal T; Casci I; Fackelmayer FO; Pennuto M; Pandey UB
    PLoS One; 2013; 8(4):e61576. PubMed ID: 23620769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of alkyl bis(oxy)dibenzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors.
    Zhang WY; Lu WC; Jiang H; Lv ZB; Xie YQ; Lian FL; Liang ZJ; Jiang YX; Wang DJ; Luo C; Jin J; Ye F
    Chem Biol Drug Des; 2017 Dec; 90(6):1260-1270. PubMed ID: 28636189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting PRMT1-mediated FLT3 methylation disrupts maintenance of MLL-rearranged acute lymphoblastic leukemia.
    Zhu Y; He X; Lin YC; Dong H; Zhang L; Chen X; Wang Z; Shen Y; Li M; Wang H; Sun J; Nguyen LX; Zhang H; Jiang W; Yang Y; Chen J; Müschen M; Chen CW; Konopleva MY; Sun W; Jin J; Carlesso N; Marcucci G; Luo Y; Li L
    Blood; 2019 Oct; 134(15):1257-1268. PubMed ID: 31395602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward the development of potent and selective bisubstrate inhibitors of protein arginine methyltransferases.
    Dowden J; Hong W; Parry RV; Pike RA; Ward SG
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2103-5. PubMed ID: 20219369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAM98A is a novel substrate of PRMT1 required for tumor cell migration, invasion, and colony formation.
    Akter KA; Mansour MA; Hyodo T; Ito S; Hamaguchi M; Senga T
    Tumour Biol; 2016 Apr; 37(4):4531-9. PubMed ID: 26503212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia.
    Zhou L; Jia X; Shang Y; Sun Y; Liu Z; Liu J; Jiang W; Deng S; Yao Q; Chen J; Li H
    Mol Carcinog; 2023 Aug; 62(8):1119-1135. PubMed ID: 37144835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of C/EBPα by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer.
    Liu LM; Sun WZ; Fan XZ; Xu YL; Cheng MB; Zhang Y
    Cancer Res; 2019 Jun; 79(11):2865-2877. PubMed ID: 31015230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.